NORTH READING, Mass., Feb. 12, 2018 /PRNewswire/ -- TraceLink Inc., the World's Largest Track and Trace Network for connectingthe life sciences supply chain and providing real-time information sharing for better patient outcomes, today announced financial and company results for the fourth quarter and full year of 2017.
Quarterly and annual growth highlights for 2017
"This past year was a collection of major accomplishments for the company as we successfully expanded our global market leadership position in the US, EMEA and APAC and increased worldwide customer adoption of the Life Sciences Cloud," said Shabbir Dahod, president and CEO, TraceLink. "2018 is a pivotal year for both the US and Europe as companies finalize their serialization preparations to meet their respective November 2018 and February 2019 deadlines. With our proven Life Sciences Cloud and information-sharing network, companies can rest assured that TraceLink is their long-term partner in helping them derive transformative value from a truly digital supply chain – from compliance and operational efficiency to patient engagement."
Additional Q4 2017 growth highlights and milestones include:
TraceLink is the World's Largest Track and Trace Network for connecting the Life Sciences supply chain and eliminating counterfeit prescription drugs from the global marketplace. Leading businesses trust the TraceLink Life Sciences Cloud to deliver complete global connectivity, visibility and traceability of pharmaceuticals from ingredient to patient. A single point and click connection to the Life Sciences Cloud creates a supply chain control tower that delivers the information, insight and collaboration needed to improve performance and reduce risk across global supply, manufacturing and distribution operations. A winner of numerous industry awards including three consecutive years on Deloitte's Technology Fast 500 (ranked number 177 in 2017), the Amazon AWS Global Start-Up Challenge Grand Prize, and the Edison Award for Innovation in Health Management, the Life Sciences Cloud is used by businesses across the globe to meet strategic goals in ensuring global compliance, fighting drug counterfeiting, improving on-time and in-full delivery, protecting product quality and reducing operational cost. For more information on TraceLink and our solutions, visit www.tracelink.com or follow us on LinkedIn, Twitter and Facebook.
TraceLink is funded by Goldman Sachs, FirstMark Capital, Volition Capital and F-Prime Capital.
View original content:http://www.prnewswire.com/news-releases/tracelink-achieves-97-revenue-growth-in-q4-and-85-overall-revenue-growth-for-2017-300597086.html
Subscribe to our Free Newsletters!
Birth Control Implant is a long-acting birth control contraceptive inserted into the arm. It is a ...
Mastocytosis is a rare condition marked by accumulation of mast cells under the skin and various ...
Lusutrombopag is used to treat abnormally low platelet counts (thrombocytopenia) in adult patients ...View All